Founders Financial Securities’s DexCom DXCM Stock Holding History

Founders Financial Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,483	Closed	-$325K	–	372
2023 Q3	$325K	Buy	3,483 +246	+8%	+$27.7K	0.04%	262
2023 Q2	$416K	Buy	3,237 +263	+9%	+$31.8K	0.05%	234
2023 Q1	$346K	Buy	2,974 +133	+5%	+$14.9K	0.05%	248
2022 Q4	$322K	Sell	2,841 -3	-0.1%	-$329	0.05%	247
2022 Q3	$229K	Sell	2,844 -78	-3%	-$6.61K	0.04%	272
2022 Q2	$218K	Buy	2,922 +438	+18%	+$40K	0.04%	232
2022 Q1	$318K	Buy	2,484 +512	+26%	+$56K	0.06%	208
2021 Q4	$265K	Buy	1,972 +72	+4%	+$10.3K	0.05%	221
2021 Q3	$260K	Buy	+1,900	New	+$240K	0.05%	226

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Founders Financial Securities's DXCM Position: Q4 2023 in Review

Founders Financial Securities sold out of DexCom (DXCM) in Q4 2023, closing a stake of 3,483 shares — an estimated $325K sold.

Founders Financial Securities first reported a position in DXCM in Q3 2021 and held it in 9 quarters. The position peaked at $416K in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Founders Financial Securities reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Founders Financial Securities sold 3,483 DexCom shares in Q4 2023, an estimated $325K.
Founders Financial Securities first reported a position in DexCom in Q3 2021 and held it in 9 quarters.
Founders Financial Securities's DexCom position peaked at $416K in Q2 2023.
974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Founders Financial Securities's 13F filing for Q4 2023, filed 6 Feb 2024.